Home > D. Systemic pathology > Toxics and drugs > Therapeutics > Targeted therapy > Pathway-targeted therapy > ERBB2-targeted therapy

ERBB2-targeted therapy

Wednesday 23 November 2011

References

- Truncated HER2: implications for HER2-targeted therapeutics. Zagozdzon R, Gallagher WM, Crown J. Drug Discov Today. 2011 Sep;16(17-18):810-6. PMID: #21704182#